Melo EB - Search Results

1

Correction: Flavonoid as possible therapeutic targets against COVID-19: a scoping review of in silico studies.

Toigo L, Dos Santos Teodoro EI, Guidi AC, Gancedo NC, Petruco MV, Melo EB, Tonin FS, Fernandez-Llimos F, Chierrito D, de Mello JCP, de Medeiros Araújo DC, Sanches ACC. Toigo L, et al. Among authors: melo eb. Daru. 2024 Jun;32(1):469. doi: 10.1007/s40199-023-00469-9. Daru. 2024. PMID: 37597115 Free article. No abstract available.

2

Flavonoid as possible therapeutic targets against COVID-19: a scoping review of in silico studies.

Toigo L, Dos Santos Teodoro EI, Guidi AC, Gancedo NC, Petruco MV, Melo EB, Tonin FS, Fernandez-Llimos F, Chierrito D, de Mello JCP, de Medeiros Araújo DC, Sanches ACC. Toigo L, et al. Among authors: melo eb. Daru. 2023 Jun;31(1):51-68. doi: 10.1007/s40199-023-00461-3. Epub 2023 May 17. Daru. 2023. PMID: 37195402 Free PMC article. Review.

3

The naturally-derived alkaloids as a potential treatment for COVID-19: A scoping review.

Gonzalez BL, de Oliveira NC, Ritter MR, Tonin FS, Melo EB, Sanches ACC, Fernandez-Llimos F, Petruco MV, de Mello JCP, Chierrito D, de Medeiros Araújo DC. Gonzalez BL, et al. Among authors: melo eb. Phytother Res. 2022 Jul;36(7):2686-2709. doi: 10.1002/ptr.7442. Epub 2022 Mar 30. Phytother Res. 2022. PMID: 35355337 Free PMC article. Review.

4

Development and characterization of lipid-polymeric nanoparticles for oral insulin delivery.

Sgorla D, Lechanteur A, Almeida A, Sousa F, Melo E, Bunhak É, Mainardes R, Khalil N, Cavalcanti O, Sarmento B. Sgorla D, et al. Expert Opin Drug Deliv. 2018 Mar;15(3):213-222. doi: 10.1080/17425247.2018.1420050. Epub 2017 Dec 27. Expert Opin Drug Deliv. 2018. PMID: 29257904 Free article.

5

Patient safety with covid-19 in hospital units: a scoping review.

Leite FMC, Oliveira EDS, Silva BVSD, Melo EBB, Dantas RAN, Dantas DV. Leite FMC, et al. Among authors: melo ebb. Rev Bras Enferm. 2023 Oct 9;76Suppl 1(Suppl 1):e20220557. doi: 10.1590/0034-7167-2022-0557. eCollection 2023. Rev Bras Enferm. 2023. PMID: 37820105 Free PMC article. Review.

6

Multivariate QSAR, similarity search and ADMET studies based in a set of methylamine derivatives described as dopamine transporter inhibitors.

de Oliveira LHD, Cruz JN, Dos Santos CBR, de Melo EB. de Oliveira LHD, et al. Among authors: de melo eb. Mol Divers. 2023 Sep 6. doi: 10.1007/s11030-023-10724-5. Online ahead of print. Mol Divers. 2023. PMID: 37670118

7

Naringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant: a study based on molecular docking, molecular dynamics, MM/PBSA and MM/GBSA.

Cobre AF, Maia Neto M, de Melo EB, Fachi MM, Ferreira LM, Tonin FS, Pontarolo R. Cobre AF, et al. Among authors: de melo eb. J Biomol Struct Dyn. 2023 Jul 2:1-14. doi: 10.1080/07391102.2023.2229446. Online ahead of print. J Biomol Struct Dyn. 2023. PMID: 37394802

8

Massage for pain relief in newborns submitted to puncture: systematic review.

Costa TMS, Oliveira EDS, Silva BVSD, Melo EBB, Carvalho FO, Duarte FHDS, Dantas RAN, Dantas DV. Costa TMS, et al. Among authors: melo ebb. Rev Gaucha Enferm. 2022 Nov 28;43(spe):e20220029. doi: 10.1590/1983-1447.2022.20220029.en. eCollection 2022. Rev Gaucha Enferm. 2022. PMID: 36449833 Free article. English, Portuguese.

9

Pharmacophore modeling, molecular docking, and molecular dynamics studies to identify new 5-HT_2AR antagonists with the potential for design of new atypical antipsychotics.

Martins AF, de Campos LJ, Conda-Sheridan M, de Melo EB. Martins AF, et al. Among authors: de melo eb. Mol Divers. 2023 Oct;27(5):2217-2238. doi: 10.1007/s11030-022-10553-y. Epub 2022 Nov 21. Mol Divers. 2023. PMID: 36409431

10

Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19: a scoping review.

de Matos PH, da Silva TP, Mansano AB, Gancedo NC, Tonin FS, Pelloso FC, Petruco MV, de Melo EB, Fernandez-Llimos F, Sanches ACC, de Mello JCP, Chierrito D, de Medeiros Araújo DC. de Matos PH, et al. Among authors: de melo eb. Inflamm Res. 2022 Dec;71(12):1489-1500. doi: 10.1007/s00011-022-01642-7. Epub 2022 Oct 28. Inflamm Res. 2022. PMID: 36307652 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page